Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-20
1999-08-10
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514423, A61K 31475
Patent
active
059359676
ABSTRACT:
Pharmaceutical formulations of highly lipophilic, poorly water soluble derivatives of Camptothecin are disclosed. The formulations include an effective amount of the HLCD dissolved or suspended in an appropriate amount of N-methyl-2-pyrrolidinone (NMP), and one or more pharmaceutically acceptable excipients.
REFERENCES:
patent: 5422361 (1995-06-01), Munayyer et al.
patent: 5447936 (1995-09-01), Hausheer et al.
patent: 5468754 (1995-11-01), Hausheer et al.
patent: 5573781 (1996-11-01), Brown et al.
Haridas Kochat
Hausheer Frederick H.
Murali Dhanabalan
Reddy Dasharatha Gauravaram
BioNumerik Pharmaceuticals, Inc.
Cook Rebecca
Dodd Thomas J.
LandOfFree
Pharmaceutical formulations of highly lipophilic camptothecin de does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulations of highly lipophilic camptothecin de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations of highly lipophilic camptothecin de will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1120460